What is ADGM's current stock price?

ADGM (Adagio Medical Holdings, Inc.) is currently trading at $0.84 with a market cap of $12.8M.

What sector is Adagio Medical Holdings, Inc. in?

Adagio Medical Holdings, Inc. (ADGM) operates in the Healthcare sector, specifically in the Medical - Devices industry.

Is ADGM a good stock to buy?

Analysts have a Buy consensus on ADGM with a price target of $3.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

ADGM Adagio Medical Holdings, Inc.

Healthcare

$0.84-0.46%ClosedMarket Cap: $12.8M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

3.26

P/S

0.00

EV/EBITDA

-1.30

DCF Value

$-0.25

FCF Yield

-121.8%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-382.5%

ROA

-62.0%

ROIC

-63.3%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-7.0M	$—
Q4 null	$0.00	$-3.3M	$—
FY null	$0.00	$-25.1M	$—
Q3 null	$0.00	$-10.1M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$3.00

Target (Median)

$3.00

Target Range

$3.00 - $3.00

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

Usen Todddirector, officer: Chief Executive Officer

SellMon Mar 09

Kaster Deborahofficer: Chief Financial Officer

SellMon Mar 09

Kaster Deborahofficer: Chief Financial Officer

BuyThu Dec 18

Usen Todddirector, officer: Chief Executive Officer

BuyMon Dec 15

Salmon Seandirector

SellThu Dec 11

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

Exchange

—

Beta

-0.14

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Peers